Related references
Note: Only part of the references are listed.Overdiagnosis in lung cancer screening: Estimates from the German Lung Cancer Screening Intervention Trial
Sandra Gonzalez Maldonado et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Addressing harms of screening - A review of outcomes in Cochrane reviews and suggestions for next steps
Minna Johansson et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
Usha Menon et al.
LANCET (2021)
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial
Stephen W. Duffy et al.
LANCET ONCOLOGY (2020)
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
Jonas Hugosson et al.
EUROPEAN UROLOGY (2019)
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
U. Pastorino et al.
ANNALS OF ONCOLOGY (2019)
Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial
Michael W. Marcus et al.
THORAX (2019)
Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial
Paul F. Pinsky et al.
BJU INTERNATIONAL (2019)
Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis
Dragan Ilic et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval
Uraujh Yousaf-Khan et al.
THORAX (2017)
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial
Eugenio Paci et al.
THORAX (2017)
How to conduct research on overdiagnosis. A keynote paper from the EGPRN May 2016, Tel Aviv
John Brodersen
EUROPEAN JOURNAL OF GENERAL PRACTICE (2017)
Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies
Roman Gulati et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
Albert L. Siu et al.
ANNALS OF INTERNAL MEDICINE (2016)
Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial
Sue M. Moss et al.
LANCET ONCOLOGY (2015)
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods
Jamie L. Carter et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods
Jamie L. Carter et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Overdiagnosis: How cancer screening can turn indolent pathology into illness
John Brodersen et al.
APMIS (2014)
Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial
Anthony B. Miller et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis
P-H Zahl et al.
BRITISH JOURNAL OF CANCER (2013)
The benefits and harms of breast cancer screening: an independent review
M. G. Marmot et al.
BRITISH JOURNAL OF CANCER (2013)
Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension
Alex Hodkinson et al.
BMJ OPEN (2013)
Quantification of harms in cancer screening trials: literature review
Bruno Heleno et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time
Stephen W. Duffy et al.
BREAST CANCER RESEARCH (2013)
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
Virginia A. Moyer
ANNALS OF INTERNAL MEDICINE (2012)
Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial
Ugo Pastorino et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2012)
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
Gerald L. Andriole et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
Zaigham Saghir et al.
THORAX (2012)
Interpreting Overdiagnosis Estimates in Population-based Mammography Screening
Rianne de Gelder et al.
EPIDEMIOLOGIC REVIEWS (2011)
Screening by Chest Radiograph and Lung Cancer Mortality The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial
Martin M. Oken et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Randomised prostate cancer screening trial: 20 year follow-up
Gabriel Sandblom et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Overdiagnosis in Cancer
H. Gilbert Welch et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
15-Year Followup of a Population Based Prostate Cancer Screening Study
Anders Kiellman et al.
JOURNAL OF UROLOGY (2009)
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Overdiagnosis in organised mammography screening in Denmark. A comparative study
Karsten J Jørgensen et al.
BMC Womens Health (2009)
Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review
Corne Biesheuvel et al.
LANCET ONCOLOGY (2007)
Overstating the evidence for lung cancer screening - The international early lung cancer action program (I-ELCAP) study
H. Gilbert Welch et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial
Sue M. Moss et al.
LANCET (2006)
Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study
S Zackrisson et al.
BRITISH MEDICAL JOURNAL (2006)
Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years
S Moss et al.
BRITISH JOURNAL OF CANCER (2005)
Clinical consequences of screening for prostate cancer:: 15 years follow-up of a randomised controlled trial in Sweden
G Sandblom et al.
EUROPEAN UROLOGY (2004)
Randomized controlled trial of screening for hepatocellular carcinoma
BH Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Better reporting of harms in randomized trials: An extension of the CONSORT statement
JPA Ioannidis et al.
ANNALS OF INTERNAL MEDICINE (2004)
The Canadian National Breast Screening Study-1: Breast cancer mortality after 11 to 16 years of follow-up - A randomized screening trial of mammography in women age 40 to 49 years
AB Miller et al.
ANNALS OF INTERNAL MEDICINE (2002)
Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years
AB Miller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
